Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

Sleep apnea, a condition affecting more than 12 million Americans, can lead to a host of health problems including heart disease. But, a new treatment containing ingredients derived from cannabis is ...

The pill showed "significant" reductions in airway obstruction after 26 weeks. The first oral pill for obstructive sleep apnea (OSA) could be around the corner after pharmaceutical company Apnimed Inc ...